SynthesisInflammopharmacology2026

A novel oral interleukin-23 receptor antagonist peptide, icotrokinra, for moderate-to- severe plaque psoriasis: a systematic review and meta-analysis of randomized controlled trials.

Martin Cevallos-Cueva et al.PubMed ↗Publisher ↗

No numbers read from the abstract.